Cost-effectiveness analysis of COVID-19 booster vaccination with BNT162b2 in Japan

Author:

Nagano Mitsuhiro1,Kamei Kazumasa1,Matsuda Hiroyuki2,Takahashi Chihiro3,Yang Jingyan45,Wada Koji3,Yonemoto Naohiro1

Affiliation:

1. Health and Value, Pfizer Japan Inc., Tokyo, Japan

2. RWES HEOR, IQVIA Solutions Japan G.K., Tokyo, Japan

3. mRNA & Antiviral Medical Affairs, Pfizer Japan Inc., Tokyo, Japan

4. Global Access and Value, Pfizer Inc., New York, NY, USA

5. Institute for Social and Economic Research and Policy, Columbia University, New York, NY, USA

Funder

Pfizer Japan Inc

Publisher

Informa UK Limited

Reference57 articles.

1. World Health Organization. WHO coronavirus (COVID-19 dashboard). 2023 Sep 26 [cited 2023 Sep 26]. Available from: https://covid19.who.int/?adgroupsurvey=%7Badgroupsurvey%7D&gclid=Cj0KCQiAw8OeBhCeARIsAGxWtUxR9wuVfKmK8awaDLSRrSm65bKiEJOcvWX34XpP2LX4eD_sR9ZfUqAaArNPEALw_wcB

2. COVID-19 vaccination: The road ahead

3. COVID-19 Vaccine Booster Strategies in Light of Emerging Viral Variants: Frequency, Timing, and Target Groups

4. COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future Prospects

5. Effectiveness of COVID-19 Vaccine Booster Shot Compared with Non-Booster: A Meta-Analysis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3